Illumina Says New HumanOmni Chip 'Important Flagship' for Next Round of GWAS | GenomeWeb

This article has been corrected from a previous version that inaccurately described the content on Illumina's HumanOmni1-Quad and Human660W-Quad BeadChips.

The 4-million feature HumanOmni1-Quad BeadChip that Illumina launched this week is the first of a new family of arrays that include rare variant content generated by the 1000 Genomes Project and other sources.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.